Literature DB >> 30774268

Bile Acids in Hepatic Encephalopathy.

Sharon DeMorrow1,2.   

Abstract

Hepatic encephalopathy describes the array of neurological complications that arise due to liver insufficiency and/or portal-systemic shunt. The pathogenesis of hepatic encephalopathy shares a longstanding association with hyperammonemia and inflammation. Recently, aberrant bile acid signaling has been implicated in the development of key features of hepatic encephalopathy due to acute liver failure including neuronal dysfunction, neuroinflammation and blood-brain barrier permeability. This review summarizes the findings of recent studies demonstrating a role for bile acids in hepatic encephalopathy and speculates on the possible downstream consequences of bile acid signaling.

Entities:  

Keywords:  ASBT, Apical Sodium-Dependent Bile Acid Transporter; CCL2, Chemokine Ligand 2; CCR2, Chemokine Receptor 2; Cyp46A1, Cytochrome p450 46A1; FXR, Farnesoid X Receptor; GR, Glucocorticoid Receptor; NTCP, Sodium Taurocholate Cotransporting Polypeptide; PXR, Pregnane X Receptor; S1P2R, Sphingosine 1 Phosphate Receptor 2; TGR5, Takeda G-Protein Receptor 5; Takeda G-protein coupled receptor 5 (TGR5); VDR, Vitamin D Receptor; blood–brain barrier; farnesoid X receptor; neuroinflammation; sphingosine-1-phosphate receptor 2

Year:  2018        PMID: 30774268      PMCID: PMC6363980          DOI: 10.1016/j.jceh.2018.04.011

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  55 in total

Review 1.  The continuing importance of bile acids in liver and intestinal disease.

Authors:  A F Hofmann
Journal:  Arch Intern Med       Date:  1999 Dec 13-27

2.  Identification of membrane-type receptor for bile acids (M-BAR).

Authors:  Takaharu Maruyama; Yasuhisa Miyamoto; Takao Nakamura; Yoshitaka Tamai; Hiromasa Okada; Eiji Sugiyama; Tatsuji Nakamura; Hiraku Itadani; Kenichi Tanaka
Journal:  Biochem Biophys Res Commun       Date:  2002-11-15       Impact factor: 3.575

3.  Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover.

Authors:  Erik G Lund; Chonglun Xie; Tiina Kotti; Stephen D Turley; John M Dietschy; David W Russell
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

4.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.

Authors:  J L Staudinger; B Goodwin; S A Jones; D Hawkins-Brown; K I MacKenzie; A LaTour; Y Liu; C D Klaassen; K K Brown; J Reinhard; T M Willson; B H Koller; S A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

5.  Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model.

Authors:  K A Matkowskyj; J A Marrero; R E Carroll; A V Danilkovich; R M Green; R V Benya
Journal:  Am J Physiol       Date:  1999-08

Review 6.  Hepatic encephalopathy: An update of pathophysiologic mechanisms.

Authors:  A S Hazell; R F Butterworth
Journal:  Proc Soc Exp Biol Med       Date:  1999-11

Review 7.  Complications of cirrhosis III. Hepatic encephalopathy.

Authors:  R F Butterworth
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

8.  Lack of detrimental effects of nitric oxide inhibition in bile duct-ligated rats with hepatic encephalopathy.

Authors:  C-Y Chan; S-W Huang; T-F Wang; R-H Lu; F-Y Lee; F-Y Chang; C-J Chu; Y-C Chen; C-C Chan; H-C Huang; S-D Lee
Journal:  Eur J Clin Invest       Date:  2004-02       Impact factor: 4.686

9.  A G protein-coupled receptor responsive to bile acids.

Authors:  Yuji Kawamata; Ryo Fujii; Masaki Hosoya; Masataka Harada; Hiromi Yoshida; Masanori Miwa; Shoji Fukusumi; Yugo Habata; Takashi Itoh; Yasushi Shintani; Shuji Hinuma; Yukio Fujisawa; Masahiko Fujino
Journal:  J Biol Chem       Date:  2003-01-10       Impact factor: 5.157

10.  Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals.

Authors:  Ryutaro Adachi; Andrew I Shulman; Keiko Yamamoto; Iichiro Shimomura; Sachiko Yamada; David J Mangelsdorf; Makoto Makishima
Journal:  Mol Endocrinol       Date:  2003-10-02
View more
  9 in total

1.  Cholestasis alters brain lipid and bile acid composition and compromises motor function in neonatal piglets.

Authors:  Nicole Lind Henriksen; Svend Høime Hansen; Matthew Domenic Lycas; Xiaoyu Pan; Thomas Eriksen; Lars Søndergaard Johansen; Richard R Sprenger; Christer Stenby Ejsing; Douglas G Burrin; Kerstin Skovgaard; Vibeke Brix Christensen; Thomas Thymann; Stanislava Pankratova
Journal:  Physiol Rep       Date:  2022-07

2.  A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation.

Authors:  Roosmarijn E Vandenbroucke; Christophe Van Steenkiste; Wouter Claeys; Lien Van Hoecke; Anja Geerts; Hans Van Vlierberghe; Sander Lefere; Griet Van Imschoot; Elien Van Wonterghem; Bart Ghesquière
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

Review 3.  Hepatic Encephalopathy: Thinking Beyond Ammonia.

Authors:  Hanna Blaney; Sharon DeMorrow
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-01-24

Review 4.  Brain Edema in Chronic Hepatic Encephalopathy.

Authors:  Cristina Cudalbu; Simon D Taylor-Robinson
Journal:  J Clin Exp Hepatol       Date:  2019-02-19

5.  Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease.

Authors:  Priyanka Baloni; Cory C Funk; Jingwen Yan; James T Yurkovich; Alexandra Kueider-Paisley; Kwangsik Nho; Almut Heinken; Wei Jia; Siamak Mahmoudiandehkordi; Gregory Louie; Andrew J Saykin; Matthias Arnold; Gabi Kastenmüller; William J Griffiths; Ines Thiele; Rima Kaddurah-Daouk; Nathan D Price
Journal:  Cell Rep Med       Date:  2020-11-17

Review 6.  The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy.

Authors:  Zefeng Chen; Jingsheng Ruan; Dinghua Li; Min Wang; Zhiwei Han; Wenxia Qiu; Guobin Wu
Journal:  Front Cell Infect Microbiol       Date:  2021-01-21       Impact factor: 5.293

Review 7.  Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives.

Authors:  Alba Rocco; Costantino Sgamato; Debora Compare; Pietro Coccoli; Olga Maria Nardone; Gerardo Nardone
Journal:  Front Cell Dev Biol       Date:  2021-11-26

8.  Characterization of intestinal microbiota and serum metabolites in patients with mild hepatic encephalopathy.

Authors:  Yong Lin; Gengjie Yan; Feng Feng; Minggang Wang; Fuli Long
Journal:  Open Life Sci       Date:  2022-03-10       Impact factor: 0.938

9.  Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species.

Authors:  Yoshimi Yukawa-Muto; Tomonori Kamiya; Hideki Fujii; Hiroshi Mori; Atsushi Toyoda; Ikuya Sato; Yusuke Konishi; Akiyoshi Hirayama; Eiji Hara; Shinji Fukuda; Norifumi Kawada; Naoko Ohtani
Journal:  Hepatol Commun       Date:  2022-04-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.